All blog posts
Total 8 results for
Showing 8 out of 8 results
03 março 2025
Latest CRTea podcast now available: Navigating competition law and FDI regulation in the pharmaceuticals sector - 2025 Outlook
06 dezembro 2023
Competition law and biosimilars: Time for a new approach or not yet?
23 novembro 2023
CMA issues guidance permitting drugs companies to work together on Combination Therapies
15 agosto 2023
CAT upholds CMA excessive pricing decision in liothyronine tablets case
09 fevereiro 2023
Competition law developments in the pharma sector – 2022 round-up and what to expect in 2023
09 fevereiro 2022
Competition law in the pharma sector – Developments and what’s to come in 2022
16 fevereiro 2021
Excessive pricing: EU Commission accepts Aspen’s drug pricing commitments
27 outubro 2020
Pharmaceutical sector under increased antitrust scrutiny in the UK
Showing 8 out of 8 results
Key contacts
Kyriakos Fountoukakos
Managing Partner, Competition/Antitrust, Regulation and Trade, Brussels
Veronica Roberts
Partner, Head of Competition/Antitrust, Regulation and Trade, UK, London
Linda Evans
Partner, Head of Competition/Antitrust, Regulation and Trade, Australia, Sydney
Adelaide Luke
Partner, Head of Competition, Asia, Hong Kong
Jean Meijer
Managing Partner, Johannesburg Office, Johannesburg
Kristien Geeurickx
Knowledge Counsel, London